X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PLETHICO PHARMA TTK HEALTHCARE/
PLETHICO PHARMA
 
P/E (TTM) x 29.1 -1.1 - View Chart
P/BV x 5.4 0.0 31,929.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 TTK HEALTHCARE   PLETHICO PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PLETHICO PHARMA
Mar-14
TTK HEALTHCARE/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs663395 168.0%   
Low Rs39931 1,274.8%   
Sales per share (Unadj.) Rs535.6604.4 88.6%  
Earnings per share (Unadj.) Rs15.932.5 49.1%  
Cash flow per share (Unadj.) Rs20.051.3 39.0%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.6473.6 29.1%  
Shares outstanding (eoy) m7.7734.08 22.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.4 281.3%   
Avg P/E ratio x33.36.6 507.7%  
P/CF ratio (eoy) x26.54.2 638.9%  
Price / Book Value ratio x3.90.5 857.8%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1277,262 56.8%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6071,596 38.0%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16220,598 20.2%  
Other income Rs m61386 15.8%   
Total revenues Rs m4,22320,984 20.1%   
Gross profit Rs m1972,818 7.0%  
Depreciation Rs m32642 4.9%   
Interest Rs m301,593 1.9%   
Profit before tax Rs m197969 20.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-138 -52.6%   
Profit after tax Rs m1241,107 11.2%  
Gross profit margin %4.713.7 34.6%  
Effective tax rate %37.0-14.3 -259.0%   
Net profit margin %3.05.4 55.4%  
BALANCE SHEET DATA
Current assets Rs m1,62918,877 8.6%   
Current liabilities Rs m1,05811,896 8.9%   
Net working cap to sales %13.733.9 40.5%  
Current ratio x1.51.6 97.0%  
Inventory Days Days3036 82.9%  
Debtors Days Days34198 17.0%  
Net fixed assets Rs m5569,861 5.6%   
Share capital Rs m78341 22.8%   
"Free" reserves Rs m87812,331 7.1%   
Net worth Rs m1,06916,139 6.6%   
Long term debt Rs m1594,706 3.4%   
Total assets Rs m2,39933,146 7.2%  
Interest coverage x7.61.6 471.3%   
Debt to equity ratio x0.10.3 50.9%  
Sales to assets ratio x1.70.6 279.1%   
Return on assets %6.48.1 78.7%  
Return on equity %11.66.9 168.9%  
Return on capital %18.512.3 150.1%  
Exports to sales %0.821.4 3.7%   
Imports to sales %1.415.2 9.2%   
Exports (fob) Rs m334,402 0.7%   
Imports (cif) Rs m583,136 1.9%   
Fx inflow Rs m334,402 0.7%   
Fx outflow Rs m633,184 2.0%   
Net fx Rs m-301,219 -2.5%   
CASH FLOW
From Operations Rs m1272,437 5.2%  
From Investments Rs m-146-6,265 2.3%  
From Financial Activity Rs m222,490 0.9%  
Net Cashflow Rs m3-1,337 -0.2%  

Share Holding

Indian Promoters % 65.4 82.7 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.3 86.0%  
FIIs % 5.2 5.5 94.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 7.5 344.0%  
Shareholders   12,723 10,665 119.3%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PANACEA BIOTECH  BIOCON LTD  UNICHEM LAB  NATCO PHARMA  AJANTA PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Vishal Sikka's Infosys Exit, White House Shake up & Cues to Watch Out Today(Pre-Open)

Indian share markets ended lower on Friday but gained during the overall week. At the closing bell on Friday, BSE Sensex closed lower by 271 points and the NSE Nifty finished down 67 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 18, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ELDER PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS